Navigation Links
Munich researchers demonstrate rocking movement in the anti-stress protein Hsp90
Date:8/23/2010

The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universitaet Muenchen (TUM) uncovered this protein's mode of operation some time ago but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.

Proteins are the motors of the cell: They transport, among other things, nutrients, move our muscles, convert substances chemically or fold other proteins. The so-called heat shock protein Hsp90 is eminently important for our cells since it plays a decisive role in many basic processes in humans as well as in bacteria or yeasts. For example, it is decisive in folding polypeptide chains into functioning proteins with very precisely defined spatial structures. Especially when cells are exposed to stress through heat or poisonous substances, Hsp90 production increases to keep the damage in check.

The anti-stress protein is a dimer (which consists of two identical proteins) and can be roughly divided into three segments: the N terminal domain at the top, the middle domain and the C terminal at the bottom. Hsp90 taps the energy it requires for its work from the slow splitting of ATP, the fuel of every cell. In this process, the two strands move in opposing directions, albeit only a few nanometers. The TUM groups of Prof. Thorsten Hugel from the Department of Physics and Prof. Johannes Buchner from the Department of Chemistry are quite familiar with the movement of Hsp90: They were the first to observe the scissor-like movement in real-time. Yet even they were caught off guard: Instead of the familiar one-ended scissor movement at the N terminal domains they were now observing the rocking movement at both ends of the protein.

Hsp90 opens and closes in a scissors-like manner at the C terminal as well something hitherto unknown in dimers. The researchers relied on the so-called FRET technology (FRET = Frster Resonance Energy Transfer) in their new study. They attached two fluorescent molecules at precisely defined positions in the Hsp90 and used these as a molecular ruler: When one pigment is illuminated, the other glows with increasing intensity the closer the two pigments get to each other. Using this effect, they were able to observe the nanometer-scale, double-ended scissor movement in individual Hsp90 dimers using a specially constructed microscope which allowed to study single molecules.

Particularly interesting is that the double scissor movements at the N and C terminals are closely coupled: The Hsp90 dimer obviously opens and closes in alternation at each end, like a rocker. "That explains the great stability of the dimer otherwise Hsp90 would fall apart much faster," explains Thorsten Hugel. His team was also very surprised by the mechanism regulating the speed of the rocking motion: it is the ATP bound at the N terminal domains that regulates the motion at the C terminal end. The researchers showed this by switching off the dimer's ATP energy supply. The team concluded that Hsp90 communicates internally across an unusually long distance of almost ten nanometers.

The observed movement and communication patterns are interesting not only for basic research, but also for medical research since Hsp90 is a new drug target in cancer therapy. The most promising drug candidates to date block the binding of ATP at the N terminal domains of the anti-stress protein. However, these compounds may have undesirable side effects. Thanks to their new insights, the TUM researchers can now concentrate on the C terminal dimerisation of Hsp90: "There we have unique docking points for anti-cancer drugs that should function without side effects," says Hugel.


'/>"/>

Contact: Andreas Battenberg
battenberg@zv.tum.de
49-892-891-0510
Technische Universitaet Muenchen
Source:Eurekalert

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... 24, 2017 , ... Accordant Technology, a trusted IT solutions ... an analytics-first approach, layered with machine learning, that provides real-time visibility into the ... cloud to the edge. Through the new partnership, customers get the real-time situational ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... for-profit and nonprofit hospitals and health systems in the nation and help their ... institutions, led professional organizations and been instrumental in developing successful hospital and health ...
(Date:5/23/2017)... City (PRWEB) , ... May 23, 2017 , ... ... Population Health and Clinical Integration company, announced today that its iClinic V12.2 ... Home (PCMH) 2017 Prevalidation. NCQA recently introduced PCMH 2017 standards which emphasize ...
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, May 23, 2017—Total ... according to a Workers Compensation Research Institute (WCRI) study, a contrast from the ... System: CompScope™ Benchmarks, 17th Edition looks at indemnity and medical payments for ...
(Date:5/23/2017)... ... May 23, 2017 , ... London, May 23, 2017: ... serve earlier this month as a Guest Speaker and Contributor to a weeklong series ... and Common Purpose. , Walter Schindler and SAIL Capital ...
Breaking Medicine News(10 mins):
(Date:5/15/2017)... 15, 2017 Enterin Inc., a privately-held CNS pharmaceutical ... novel compounds to treat Parkinson,s disease (PD), has enrolled the ... Phase 1/2a randomized, controlled, multicenter study involving patients with PD ... 50 patients over a 9-to-12-month period. The first stage is ... with PD. Participating sites include Denver , ...
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... May 9, 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of ... Canadian Intellectual Property Office has granted Oramed a ... of Exenatide". The patent covers Oramed,s invention of ... GLP-1 is an incretin hormone that stimulates the ...
Breaking Medicine Technology: